50~5000ng/ML Neutrophil Gelatinase Associated Lipocalin Detection Reagent(NGAL) Clinical Comparison Of NGAL

NGAL overview

Gelatinase-associated lipid transporter (NGAL) is a small molecule protein expressed by neutrophils. NGAL is highly expressed in renal tubular epithelial cells and is released into the urine and blood within 2 hours after acute kidney injury. It has the characteristics of quick reaction, high specificity and little influence by other factors. Therefore, it can be used as a biomarker for early sensitive acute kidney injury and can also be used to predict the diagnosis of sepsis. High concentrations of NGAL can be detected in the urine and blood of patients with chronic kidney disease caused by a variety of diseases, so it can also be used in the diagnosis and monitoring of chronic kidney disease.

NGAL performance index

Main functions of NGAL

NGAL has powerful functions. In addition to acting as a member of the apolipoprotein family to bind and transport hydrophobic small molecules, NGAL is also involved in inflammation, embryonic development, immune response, chemotaxis, signal transduction and the occurrence and development of a variety of tumors.

NGAL can promote the differentiation of renal progenitor cells into early renal tubular epithelial cells, repair N-cadherin, up-regulate heme oxygenase and inhibit cell death.

Clinical significance of NGAL

• Early diagnosis and severity assessment of acute kidney injury
• Diagnosis and prognosis of sepsis with nephropathy
• Related to the occurrence and development of cardiovascular disease
• Effective markers of early diabetic nephropathy

Application Department

Nephrology, surgery, oncology, ICU, pediatrics, cardiology, endocrinology, Urology, etc

Clinical Comparison Of NGAL

Company profile

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purification workshop of national standards, and a fully functional inspection center. On this basis, the company will continue to invest in research and development, accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, improve product quality, and provide customers with safe and effective in vitro diagnostic products.

Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, immune series, microbial series and other reagents and supporting instruments.

The company has always adhered to the core concept of “fast and accurate, living up to life”, committed to providing society with excellent products and services, and contributing to the cause of human health.